NCT02494479View on ClinicalTrials.gov

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions
Plaque Psoriasis
Interventions
DRUG

Prurisol

50mg tablet

DRUG

Placebo

Sugar pill designed to match Purisol tablet

Trial Locations (9)

33016

Cellceutix Study Center, Hialeah

33026

Cellceutix Study Center, Pembroke Pines

33126

Cellceutix Study Center, Miami

33134

Cellceutix Study Center, Coral Gables

33144

Cellceutix Study Center, Miami

34741

Cellceutix Study Center, Kissimmee

35801

Cellceutix Study Center, Huntsville

89119

Cellceutix Study Center, Las Vegas

91436

Cellceutix Study Center, Encino

Sponsors
All Listed Sponsors
lead

Cellceutix Corporation

INDUSTRY